Pharma Journalist - Page 7 of 847 -

Sangamo and Lilly Partner on Capsid License for CNS Genomic Medicines

Boehringer Ingelheim Expands ADC Portfolio with New R&D Center in Basel

Neurona Therapeutics Raises $102M for NRTX-1001 Phase 3 Trial

Magnet Biomedicine and Lilly Partner to Develop Novel Molecular Glue Medicines

FDA Grants Priority Review to Sobi’s sBLA for Gamifant (emapalumab-lzsg)

Medigene and EpimAb Partner on Co-Development of TCR-Guided T Cell Engagers

FDA Accepts BLA for Odronextamab in Treating Relapsed/Refractory Follicular Lymphoma

Lilly to Exceed $50 Billion in U.S. Manufacturing Investment, Doubling Since 2020

Sarclisa Approved in Japan for Newly Diagnosed Multiple Myeloma Patients

RedHill Licenses RHB-102 to Hyloris for Global Commercialization, Potentially Worth $60M

Summit Therapeutics Partners with Pfizer to Trial Ivonescimab with ADCs

Mirum’s CTEXLI Tablets FDA-Approved for Cerebrotendinous Xanthomatosis

FDA Accepts BMS’ SBLAs for Opdivo + Yervoy in MSI-High, MMR-D Cancer